Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi's ...

Eli Lilly and Boehringer Ingelheim will undercut Sanofi by 15% with Basaglar, a biosimilar version of the insulin blockbuster Lantus launched today in the US.

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take ...

The company is commissioning a new cartridge facility in Bhopal and expects to capture ₹200–300 crore of the ₹450 crore opportunity in India alone, created by Novo’s exit from insulin pens ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

The company achieved a revenue of $78.35 million, marking an 18% year-over-year growth, driven by a 32% increase in Tyvaso DPI royalties and an 18% rise in collaboration and services revenue.

Discover 8 evidence-based steps to reverse insulin resistance naturally. Learn how simple daily changes can transform your metabolism and energy levels.

Star Wars: Zero Company is set to release on PC, Xbox Series X/S, and PS5. We're well past the halfway point of the current console generation, ...

Trump wants to create a master database on Americans. Palantir is the company he wants carrying it out. Credit: Jakub Porzycki/NurPhoto via Getty Images Last Friday, the New York Times published ...